Magnus Financial Group’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-2,890
Closed -$256K 247
2021
Q1
$256K Buy
+2,890
New +$287K 0.06% 190

Other funds holding ARKG

Magnus Financial Group's ARKG Position: Q2 2021 in Review

Magnus Financial Group sold out of ARK Genomic Revolution ETF (ARKG) in Q2 2021, closing a stake of 2,890 shares — an estimated $256K sold.

Magnus Financial Group first reported a position in ARKG in Q1 2021 and held it in 1 quarter. The position peaked at $256K in Q1 2021. 512 funds tracked by Wall St. Rank hold ARKG as of Q2 2021.

  • Magnus Financial Group reported no remaining ARK Genomic Revolution ETF position as of Q2 2021 after selling out during the quarter.
  • Magnus Financial Group sold 2,890 ARK Genomic Revolution ETF shares in Q2 2021, an estimated $256K.
  • Magnus Financial Group first reported a position in ARK Genomic Revolution ETF in Q1 2021 and held it in 1 quarter.
  • Magnus Financial Group's ARK Genomic Revolution ETF position peaked at $256K in Q1 2021.
  • 512 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2021.

Based on Magnus Financial Group's 13F filing for Q2 2021, filed 6 Aug 2021.